Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of postpartum oxytocin cessation after spontaneous vaginal birth
ACTRN12615001173583Phase 2Not yet recruiting
- Sponsor
- Curtin University
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH), sponsored by Curtin University. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12615001173583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001173583.